In June 2013 Breakthrough will host its second international conference on Triple Negative Breast Cancer.
Improving the limited treatment options and poor prognosis of patients with triple negative disease is a high priority for Breakthrough. This conference will provide a comprehensive look at the challenges, controversies and breakthroughs in this disease, helping to provide patients with improved outcomes in future.
This conference builds on the successful conference held in 2011 and will highlight novel laboratory approaches, innovative pre-clinical science and the latest clinical trial results. The aim is to discuss and advance our understanding of the aetiology, diagnosis and treatment of this challenging disease.
The 3 day programme covers all aspects of triple negative disease with invited plenary speakers and proffered abstracts presented as short talks or posters. We aim to create a workshop atmosphere with ample opportunity for discussion and sharing expertise across disciplines.
The Conference has been awarded 15 category 1 (external) CPD credits by the Federation of the Royal Colleges of Physicians of the United Kingdom.
We do hope you join us at this conference which will take place at Church House in London from Wednesday 26 June to Friday 28 June 2013.
Professor Andrew Tutt
Professor of Oncology
Breakthrough Breast Cancer Research Unit, Guy’s Hospital
King’s College London School of Medicine